Exploring how office-based methadone prescribing could improve treatment for opioid use disorder in New York.
Official title: Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach
Funded at New York University School of Medicine · NIH-11009694 · Data updated 2026-11-12
This study is looking at how different ways of providing methadone treatment for opioid use disorder in New York could make it easier for people to get help and lower the chances of overdoses, so that lawmakers can find the best options for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $227,861 |
| NIH project number | 1R21DA061660-01 |
| Project ID | NIH-11009694 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with opioid use disorder who may benefit from more accessible methadone treatment options.
✕Less likely to help
Patients who are not affected by opioid use disorder or those who do not require methadone treatment may not receive any benefit from this research.
What this research studies
This research investigates the potential impact of different methadone treatment delivery methods for opioid use disorder (OUD) in New York State. By using computer simulations, the study will model various policy scenarios, including office-based prescribing and pharmacy dispensing, to understand how these changes could improve access to care and reduce overdose risks. The goal is to provide evidence that can inform lawmakers about the most effective strategies for delivering methadone treatment. Patients may benefit from more accessible treatment options if these policies are implemented successfully.
Why it matters
Potential benefit: If successful, this research could lead to improved access to methadone treatment, ultimately reducing overdose rates among patients with opioid use disorder.
How similar studies have gone: Other research has shown that improving access to methadone treatment can significantly reduce overdose rates, indicating that this approach has potential for success.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Krawczyk, Noa — New York University School of Medicine
- Study coordinator: Krawczyk, Noa
Related research
Other NIH-funded projects on the same topics.
-
Actions to Decrease Disparities in Blood Pressure Control for Blacks
Aiming to help Black patients manage high blood pressure by using nurses, community health workers, and home monitoring in real-world clinics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Oxytocin's effect on social brain function in autistic adults
A group at NYU School of Medicine studies how oxytocin affects social thinking and brain activity in adults with autism.
-
COVID-19 healthcare disruptions and heart health inequities in NYC adults with multiple conditions
This project looks at how COVID-19-related gaps in care affected heart health in adults with several chronic conditions in New York City.
-
Connecting TDP-43 Pathology to Molecular Profiles in Neurodegeneration
This grant explores how specific molecular patterns in brain tissue relate to ALS and Alzheimer’s disease features, aiming to improve understanding of disease subtypes and progression.
-
INOCA-mobile heart rehab for angina and breathlessness
A mobile health-based cardiac rehabilitation program is being tested to help people with INOCA feel better and move more.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.